ID   UOK117C4
AC   CVCL_RN44
DR   Wikidata; Q54991326
RX   PubMed=21907923;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B096 ! UOK117
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=21907923; DOI=10.1016/j.ccr.2011.07.018;
RA   Tong W.-H., Sourbier C., Kovtunovych G., Jeong S.Y., Vira M.A., Ghosh M.,
RA   Romero V.V., Sougrat R., Vaulont S., Viollet B., Kim Y.-S., Lee S.,
RA   Trepel J.B., Srinivasan R., Bratslavsky G., Yang Y.-F., Linehan W.M.,
RA   Rouault T.A.;
RT   "The glycolytic shift in fumarate-hydratase-deficient kidney cancer
RT   lowers AMPK levels, increases anabolic propensities and lowers
RT   cellular iron levels.";
RL   Cancer Cell 20:315-327(2011).
//